home / stock / pstx / pstx quote
Last: | $2.94 |
---|---|
Change Percent: | -0.66% |
Open: | $3.04 |
Close: | $2.94 |
High: | $3.09 |
Low: | $2.91 |
Volume: | 215,283 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.94 | $3.04 | $2.94 | $3.09 | $2.91 | 215,283 | 07-03-2024 |
$3.02 | $2.97 | $3.02 | $3.19 | $2.95 | 457,036 | 07-02-2024 |
$3.01 | $2.87 | $3.01 | $3.055 | $2.72 | 335,843 | 07-01-2024 |
$2.92 | $2.73 | $2.92 | $2.99 | $2.69 | 1,976,373 | 06-28-2024 |
$2.72 | $2.49 | $2.72 | $2.72 | $2.41 | 532,324 | 06-27-2024 |
$2.47 | $2.57 | $2.47 | $2.61 | $2.44 | 496,449 | 06-26-2024 |
$2.58 | $2.75 | $2.58 | $2.8191 | $2.57 | 397,944 | 06-25-2024 |
$2.75 | $2.84 | $2.75 | $2.89 | $2.72 | 384,731 | 06-24-2024 |
$2.78 | $2.7 | $2.78 | $2.96 | $2.69 | 919,987 | 06-21-2024 |
$2.65 | $2.63 | $2.65 | $2.945 | $2.5819 | 1,001,799 | 06-20-2024 |
$2.64 | $2.82 | $2.64 | $2.82 | $2.635 | 240,522 | 06-19-2024 |
$2.64 | $2.82 | $2.64 | $2.82 | $2.635 | 240,522 | 06-18-2024 |
$2.81 | $2.73 | $2.81 | $2.84 | $2.73 | 201,496 | 06-17-2024 |
$2.76 | $2.79 | $2.76 | $2.82 | $2.7 | 98,022 | 06-14-2024 |
$2.85 | $2.83 | $2.85 | $2.87 | $2.74 | 101,012 | 06-13-2024 |
$2.8 | $2.88 | $2.8 | $2.98 | $2.76 | 298,529 | 06-12-2024 |
$2.75 | $2.62 | $2.75 | $2.78 | $2.62 | 250,244 | 06-11-2024 |
$2.645 | $2.67 | $2.645 | $2.78 | $2.6 | 309,444 | 06-10-2024 |
$2.69 | $2.75 | $2.69 | $2.925 | $2.69 | 232,254 | 06-07-2024 |
$2.77 | $2.88 | $2.77 | $2.88 | $2.7 | 195,890 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Poseida Therapeutics Inc. Company Name:
PSTX Stock Symbol:
NASDAQ Market:
Poseida Therapeutics Inc. Website:
Poseida Therapeutics Announces Participation in Stifel's 2024 Virtual Cell Therapy Forum PR Newswire SAN DIEGO , July 1, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advanci...
Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders PR Newswire SAN DIEGO , June 3, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differ...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024 PR Newswire Expanded strategic relationship with Astellas with new research collaboration leveraging Poseida's proprietary allogeneic CAR-T platform to develop cell therapies targeti...